The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening

doi:10.21037/tlcr.2018.08.17

Editorial

. 2018 Sep;7(Suppl 3):S236-S238.

doi: 10.21037/tlcr.2018.08.17.

The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening

Fu-Zong Wu^{1

2

3}, Pei-Lun Kuo^{4

5}, Carol C Wu⁶, Ming-Ting Wu^{1

2

3}

Affiliations

¹ Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
² Faculty of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan.
³ Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan.
⁴ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁵ Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁶ Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 30393611
PMCID: PMC6193906
DOI: 10.21037/tlcr.2018.08.17

Editorial

The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening

Fu-Zong Wu et al. Transl Lung Cancer Res. 2018 Sep.

. 2018 Sep;7(Suppl 3):S236-S238.

doi: 10.21037/tlcr.2018.08.17.

Authors

Fu-Zong Wu^{1

2

3}, Pei-Lun Kuo^{4

5}, Carol C Wu⁶, Ming-Ting Wu^{1

2

3}

Affiliations

¹ Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
² Faculty of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan.
³ Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan.
⁴ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁵ Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁶ Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 30393611
PMCID: PMC6193906
DOI: 10.21037/tlcr.2018.08.17

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
Caverly TJ, Cao P, Hayward RA, Meza R. Caverly TJ, et al. Ann Intern Med. 2018 Jul 3;169(1):1-9. doi: 10.7326/M17-2561. Epub 2018 May 29. Ann Intern Med. 2018. PMID: 29809244 Free PMC article.

Cited by

Prediction of VEGF and EGFR Expression in Peripheral Lung Cancer Based on the Radiomics Model of Spectral CT Enhanced Images.
Wu L, Li J, Ruan X, Ren J, Ping X, Chen B. Wu L, et al. Int J Gen Med. 2022 Aug 22;15:6725-6738. doi: 10.2147/IJGM.S374002. eCollection 2022. Int J Gen Med. 2022. PMID: 36039307 Free PMC article.
Impact of annual trend volume of low-dose computed tomography for lung cancer screening on overdiagnosis, overmanagement, and gender disparities.
Hsin-Hung C, En-Kuei T, Yun-Ju W, Fu-Zong W. Hsin-Hung C, et al. Cancer Imaging. 2024 Jun 12;24(1):73. doi: 10.1186/s40644-024-00716-5. Cancer Imaging. 2024. PMID: 38867342 Free PMC article.
Impact of Smoking Status on Lung Cancer Characteristics and Mortality Rates between Screened and Non-Screened Lung Cancer Cohorts: Real-World Knowledge Translation and Education.
Wu FZ, Wu YJ, Chen CS, Yang SC. Wu FZ, et al. J Pers Med. 2022 Jan 2;12(1):26. doi: 10.3390/jpm12010026. J Pers Med. 2022. PMID: 35055341 Free PMC article.
Differences in lung cancer characteristics and mortality rate between screened and non-screened cohorts.
Wu FZ, Kuo PL, Huang YL, Tang EK, Chen CS, Wu MT, Lin YP. Wu FZ, et al. Sci Rep. 2019 Dec 18;9(1):19386. doi: 10.1038/s41598-019-56025-6. Sci Rep. 2019. PMID: 31852960 Free PMC article.
Understanding East-West differences in subsolid nodules: prevalence and overdiagnosis implications in lung cancer screening.
Chang YC, Hung YC, Wu YJ, Tang EK, Wu FZ. Chang YC, et al. Ann Med. 2025 Dec;57(1):2478321. doi: 10.1080/07853890.2025.2478321. Epub 2025 Mar 12. Ann Med. 2025. PMID: 40075292 Free PMC article.

See all "Cited by" articles

References

1. de Groot PM, Wu CC, Carter BW, et al. The epidemiology of lung cancer. Transl Lung Cancer Res 2018;7:220-33. 10.21037/tlcr.2018.05.06 - DOI - PMC - PubMed
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. 10.3322/caac.21442 - DOI - PubMed
1. National Lung Screening Trial Research Team , Aberle DR, Adams AM, et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed
1. National Lung Screening Trial Research Team , Aberle DR, Berg CD, et al. The National Lung Screening Trial: Overview and Study Design. Radiology 2011;258:243-53. 10.1148/radiol.10091808 - DOI - PMC - PubMed
1. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. preventive services task force. Ann Intern Med 2014;160:311-20. 10.7326/M13-2316 - DOI - PMC - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources

[1] de Groot PM, Wu CC, Carter BW, et al. The epidemiology of lung cancer. Transl Lung Cancer Res 2018;7:220-33. 10.21037/tlcr.2018.05.06 - DOI - PMC - PubMed

[2] de Groot PM, Wu CC, Carter BW, et al. The epidemiology of lung cancer. Transl Lung Cancer Res 2018;7:220-33. 10.21037/tlcr.2018.05.06 - DOI - PMC - PubMed

[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. 10.3322/caac.21442 - DOI - PubMed

[4] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. 10.3322/caac.21442 - DOI - PubMed

[5] National Lung Screening Trial Research Team , Aberle DR, Adams AM, et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed

[6] National Lung Screening Trial Research Team , Aberle DR, Adams AM, et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed

[7] National Lung Screening Trial Research Team , Aberle DR, Berg CD, et al. The National Lung Screening Trial: Overview and Study Design. Radiology 2011;258:243-53. 10.1148/radiol.10091808 - DOI - PMC - PubMed

[8] National Lung Screening Trial Research Team , Aberle DR, Berg CD, et al. The National Lung Screening Trial: Overview and Study Design. Radiology 2011;258:243-53. 10.1148/radiol.10091808 - DOI - PMC - PubMed

[9] de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. preventive services task force. Ann Intern Med 2014;160:311-20. 10.7326/M13-2316 - DOI - PMC - PubMed

[10] de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. preventive services task force. Ann Intern Med 2014;160:311-20. 10.7326/M13-2316 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening

Affiliations

The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources